HIV REPLICATION INHIBITING PYRIMIDINES

the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, wherein the ring containing -a1=a2-a3=a4- and -b1=b2-b3=b4- represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl; n is 0 to 5; m is 1 to 4; R1 is hydrogen;...

Full description

Saved in:
Bibliographic Details
Main Authors Heeres Jan, Vinkers Hendrik Maarten, Daeyaert Frederik Frans Desiré, Palandjian Patrice, Koymans Lucien Maria Henricus, Van Aken Koen Jeanne Alfons, Janssen Paul Adriaan Jan, de Jonge Marc René, Lewi Paulus Joannes, Guillemont Jérôme Emile Georges
Format Patent
LanguageEnglish
Published 09.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and the stereochemically isomeric forms thereof, wherein the ring containing -a1=a2-a3=a4- and -b1=b2-b3=b4- represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl; n is 0 to 5; m is 1 to 4; R1 is hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyl; C1-6alkyloxycarbonyl; substituted C1-6alkyl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyloxy; substituted C1-6alkyloxyC1-6alkylcarbonyl; R2 is hydroxy, halo, optionally substituted C1-6alkyl, C3-7cycloalkyl, optionally substituted C2-6alkenyl, optionally substituted C2-6alkynyl, C1-6alkyloxy, C1-6alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(C1-6alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, -S(═O)pR6, -NH-S(═O)pR6, -C(═O)R6, -NHC(═O)H, -C(═O)NHNH2, -NHC(═O)R6, -C(═NH)R6 or a 5-membered heterocycle; X1 is -NR5-, -NH-NH-, -N═N-, -O-, -C(═O)-, C1-4alkanediyl, -CHOH-, -S-, -S(═O)p-, -X2-C1-4alkanediyl- or -C1-4alkanediyl-X2-; R3 is NHR13; NR13R14; -C(═O)-NHR13; -C(═O)-NR13R14; -C(═O)-R15; -CH═N-NH-C(═O)-R16; substituted C1-6alkyl; optionally substituted C1-6alkyloxyC1-6alkyl; substituted C2-6alkenyl; substituted C2-6alkynyl; C1-6alkyl substituted with hydroxy and a second substituent; -C(═N-O-R8)-C1-4alkyl; R7; or -X3-R7; R4 is halo, hydroxy, C1-6alkyl, C3-7cycloalkyl, C1-6alkyloxy, cyano, nitro, polyhaloC1-6alkyl, polyhaloC1-6alkyloxy, aminocarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyl, formyl, amino, mono- or di(C1-4alkyl)amino; their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.
Bibliography:Application Number: US201715655570